Latest News

Mysterious cases of illness with an unusual cause


 

In 2021, in U.S. states far removed from one another, numerous cases of melioidosis (Whitmore’s disease) sprang up, some with a fatal outcome. What is the common factor linking all of those affected? So begins the search for evidence.

No relations or common journeys

Between March and July 2021, cases of the bacterial infectious disease sprang up in Georgia, Kansas, Minnesota, and Texas, with the disease being fatal for two of those affected. Usually, cases of melioidosis occur in the United States after traveling to regions where the pathogen is prevalent. However, none of the patients had undertaken any previous international travel.

When the genomes of the bacterial strains (Burkholderia pseudomallei) were sequenced, they showed a high level of concordance, suggesting a common source of infection. The bacterial strain is similar to those that are found in Southeast Asia above all. An imported product from there was taken into consideration as the trigger.

The Centers for Disease Control and Prevention examined blood samples from the patients, as well as samples from the soil, water, food, and household items around their homes.

Aroma spray as a trigger

In October, the cause of the melioidosis was finally identified in the house of the patient from Georgia: an aromatherapy spray. The genetic fingerprint of the bacterial strain matched with that from the other patients. The common trigger was thus discovered.

The contaminated spray, with a lavender-chamomile scent for room fragrancing, was sold between February and October in some branches of Walmart, as well as in their online store. The product was therefore recalled and it was checked whether the ingredients were also being used in other products.

The CDC requested physicians to also take melioidosis into account if they were presented with acute bacterial infections that did not respond to normal antibiotics and to inquire whether the affected room spray had been used.

More information about melioidosis

Melioidosis is an infectious disease affecting humans and animals. The trigger is the bacteria B pseudomallei. The disease appears predominantly in tropical regions, especially in Southeast Asia and northern Australia.

Transmission

The bacteria can be found in contaminated water and soil. It is disseminated between humans and animals through direct contact with the infectious source, such as through inhaling dust particles or water droplets, or through consuming contaminated water or food. Human-to-human transmission is extremely rare. Recently however, tropical saltwater fish were identified as potential carriers.

Symptoms

Melioidosis has a wide range of symptoms, which can lead to its being confused with other diseases such as tuberculosis or other forms of pneumonia. There are different forms of the disease, each with different symptoms.

  • Localized infection: localized pain and swelling, fever, ulceration, and abscess.
  • Pulmonary infection: cough, chest pain, high fever, headaches, and loss of appetite
  • Bacteremia: fever, headaches, breathing problems, stomach discomfort, joint pain, and disorientation.
  • Disseminated infection: fever, weight loss, stomach or chest pain, muscle or joint pain, headaches, central nervous system infections, and epileptic seizures.

Pages

Recommended Reading

Malaria resistant to artemisinin emerging in Africa
MDedge Internal Medicine
Progress stalling on malaria elimination
MDedge Internal Medicine
COVID-19 interrupted global poliovirus surveillance and immunization
MDedge Internal Medicine
Quebec plans to fine unvaccinated adults
MDedge Internal Medicine
ACIP releases new dengue vaccine recommendations
MDedge Internal Medicine
Antimicrobial resistance linked to 1.2 million global deaths in 2019
MDedge Internal Medicine
Monkeypox quarantines not needed in U.S., Biden says
MDedge Internal Medicine
WHO to rename monkeypox because of stigma concerns
MDedge Internal Medicine
To gauge monkeypox spread, researchers eye cases in women
MDedge Internal Medicine
Researcher revisits ‘03 guidance on monkeypox in pregnant women
MDedge Internal Medicine